Fundamental shift for NHS - and for medtech investment
This article was originally published in Clinica
A revolutionary move to ensure easier local access to diagnostic services and outpatient activity is set to result in a significant expansion, redevelopment and modernisation of primary care in the UK.
You may also be interested in...
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.